Where does LifeStance Health Group's cash flow data come from?

Every line is extracted from LifeStance Health Group's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Net income	$23.2M+140%	$9.66M+206%	-$9.12M+43.6%	-$16.15M+54.7%	-$35.64M+38.0%
Depreciation and amortization	$54.32M-0.8%	$54.75M-2.2%	$55.99M-2.7%	$57.55M-7.4%	$62.14M-12.4%
Stock-based compensation	$71.32M-4.5%	$74.7M+0.8%	$74.14M+4.8%	$70.74M-4.6%	$74.18M-2.6%
Amortization of debt issuance costs	$1.02M0.0%	$1.02M-12.5%	$1.16M-12.3%	$1.33M-11.1%	$1.49M-10.4%
Change in accounts receivable	-$17.71M+50.9%	-$36.09M—	——	——	——
Change in accounts payable	-$2.5M-60.1%	-$1.56M—	——	——	——
Change in accrued liabilities	$17.04M-34.1%	$25.87M+1,251%	$1.91M—	——	——
Change in other assets	——	——	——	——	——
Change in other liabilities	——	$2.42M+53.6%	$1.58M+115%	$732K+748%	-$113K+88.2%
Other working capital changes	-$1.8M+11.2%	-$2.03M-8.4%	-$1.87M+6.0%	-$1.99M-8.6%	-$1.84M-28.2%
Net cash from operating activities	$182.35M+24.8%	$146.15M-3.2%	$150.91M+3.1%	$146.34M+16.1%	$126.01M+17.5%
Capital expenditures	$39.72M+10.0%	$36.13M+14.6%	$31.52M+19.9%	$26.28M+11.2%	$23.63M+9.6%
Acquisitions, net of cash acquired	——	——	——	——	$0—
Net cash from investing activities	-$42.87M-18.7%	-$36.13M-14.6%	-$31.52M-19.9%	-$26.28M-11.2%	-$23.63M-9.6%
Repurchases of common stock	——	——	——	——	——
Repayments of debt	$5.44M-25.0%	$7.25M-97.5%	$292.74M+0.4%	$291.66M+0.4%	$290.58M+0.4%
Taxes paid for net share settlement	$24.48M+181%	$8.71M+1.1%	$8.61M+2.5%	$8.4M+2.9%	$8.16M—
Net cash from financing activities	-$79.02M-395%	-$15.96M+11.9%	-$18.1M0.0%	-$18.11M-3.5%	-$17.49M-75.8%
Net increase (decrease) in cash	$60.46M-35.7%	$94.07M-7.1%	$101.29M-0.7%	$101.96M+20.1%	$84.89M+12.1%
Interest paid	$13.5M-24.2%	$17.8M-7.4%	$19.22M-9.0%	$21.12M-8.6%	$23.1M-7.6%
Income taxes paid	$1.31M-16.5%	$1.57M—	——	——	——
Amortization expense related to capitalized debt issuance costs	$1.02M0.0%	$1.02M-12.5%	$1.16M-12.3%	$1.33M-11.1%	$1.49M-10.4%
Accrued compensation and employee benefits	$17.04M-34.1%	$25.87M+1,251%	$1.91M—	——	——
Increase Decrease In Operating Lease Liabilities	-$46.19M+4.0%	-$48.13M+0.3%	-$48.28M-0.2%	-$48.16M+1.8%	-$49.03M-4.9%
Accrued liabilities	——	——	——	——	$6.46M-52.6%
Increase (Decrease) in Prepaid Expense and Other Assets	——	——	——	——	——
Non Cash Operating Lease Costs	$42.39M+1.2%	$41.91M+1.4%	$41.34M+1.6%	$40.7M+1.6%	$40.05M+1.4%
Other Noncash Income (Expense)	-$1.8M+11.2%	-$2.03M-8.4%	-$1.87M+6.0%	-$1.99M-8.6%	-$1.84M-28.2%
Contingent Consideration Incurred In Acquisitions Of Businesses	——	——	——	——	$0—
Purchase Of Property Plant And Equipment Included In Accounts Payable And Accrued Expenses	——	——	——	——	——
Income Taxes Paid, Net	$1.31M-16.5%	$1.57M—	——	——	——
Free cash flow	$142.63M+29.6%	$110.03M-7.8%	$119.39M-0.6%	$120.07M+17.3%	$102.38M+19.5%
Free cash flow	$142.63M+29.6%	$110.03M-7.8%	$119.39M-0.6%	$120.07M+17.3%	$102.38M+19.5%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where does LifeStance Health Group's cash flow data come from?: Every line is extracted from LifeStance Health Group's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.